 |
|
Evolution follows few of the possible paths to antibiotic resistance
April 12, 2006Bacteria gain resistance from only a handful of 120 possible five-step mutational paths in a key gene
CAMBRIDGE, Mass. - Darwinian evolution follows very few of the available mutational pathways to attain fitter proteins, researchers at Harvard University have found in a study of a gene whose mutant form increases bacterial resistance to a widely prescribed antibiotic by a factor of roughly 100,000. Their work indicates that of 120 harrowing, five-step mutational paths that theoretically could grant antibiotic resistance, only about 10 actually endow bacteria with a meaningful evolutionary advantage.
The research is published in the journal Science.
"Just as there are many alternate routes one might follow in driving from Boston to New York, one intrinsic property of DNA is that very many distinct mutational paths link any two variants of a gene," says lead author Daniel M. Weinreich, a research associate in Harvard's Department of Organismic and Evolutionary Biology. "Although this fact has been recognized for at least 35 years, its implications for evolution by natural selection have remained unexplored. Specifically, it is of great interest to determine whether natural selection regards these many mutational paths equivalently."
Weinreich and colleagues generated a series of mutants found along all 120 possible mutational trajectories involving the gene coding for the enzyme beta-lactamase, which in altered form can serve to inactivate antibiotics including penicillin and cefotaxime. Analyzing how well each variant protected host Escherichia coli cells against treatment with various concentrations of antibiotic, the scientists found that only a very small fraction of these pathways confer ever-increasing resistance in pathogenic microbes, and are therefore relevant to natural selection.
Resistance-granting mutations of beta-lactamase occur in a five-step process, with the 120 possible mutational paths representing all the possible ways in which these five point mutations can occur. Fully 102 of the 120 trajectories are inaccessible to natural selection because they create intermediates that are no more fit than the original gene, and of the remaining 18 Weinreich and colleagues observed that only about half actually had a significant probability of evolutionary occurrence.
"To be followed by an evolving population, natural selection requires that antibiotic resistance increase with each mutation," Weinreich says. "In contrast, most mutational paths of the enzymatic variant we examined fail to continuously increase resistance. Importantly, this is not a reflection of the fact that many more mutations reduce biological function than improve it, because in the present case each mutational path is composed exclusively of mutations known jointly to improve resistance."
Weinreich argues that this finding likely applies to most protein evolution, not just the beta-lactamase enzyme.Although many mutational paths lead to favored variants, only a very small fraction are likely to result in continuously improved fitness and therefore be relevant to the process of natural selection.
Harvard University
"Just as there are many alternate routes one might follow in driving from Boston to New York, one intrinsic property of DNA is that very many distinct mutational paths link any two variants of a gene," says lead author Daniel M. Weinreich, a research associate in Harvard's Department of Organismic and Evolutionary Biology. "Although this fact has been recognized for at least 35 years, its implications for evolution by natural selection have remained unexplored. Specifically, it is of great interest to determine whether natural selection regards these many mutational paths equivalently."
Weinreich and colleagues generated a series of mutants found along all 120 possible mutational trajectories involving the gene coding for the enzyme beta-lactamase, which in altered form can serve to inactivate antibiotics including penicillin and cefotaxime. Analyzing how well each variant protected host Escherichia coli cells against treatment with various concentrations of antibiotic, the scientists found that only a very small fraction of these pathways confer ever-increasing resistance in pathogenic microbes, and are therefore relevant to natural selection.
Resistance-granting mutations of beta-lactamase occur in a five-step process, with the 120 possible mutational paths representing all the possible ways in which these five point mutations can occur. Fully 102 of the 120 trajectories are inaccessible to natural selection because they create intermediates that are no more fit than the original gene, and of the remaining 18 Weinreich and colleagues observed that only about half actually had a significant probability of evolutionary occurrence.
"To be followed by an evolving population, natural selection requires that antibiotic resistance increase with each mutation," Weinreich says. "In contrast, most mutational paths of the enzymatic variant we examined fail to continuously increase resistance. Importantly, this is not a reflection of the fact that many more mutations reduce biological function than improve it, because in the present case each mutational path is composed exclusively of mutations known jointly to improve resistance."
Weinreich argues that this finding likely applies to most protein evolution, not just the beta-lactamase enzyme.Although many mutational paths lead to favored variants, only a very small fraction are likely to result in continuously improved fitness and therefore be relevant to the process of natural selection.
Harvard University
Antibiotic Resistance Current Events and Antibiotic Resistance News RSSStudy reveals why certain drug combinations backfire
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
Bacteria 'launch a shield' to resist attack
Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system.
Misuse of antibiotics not the only cause of resistance says report
The perception that antibiotic resistance is primarily the undesirable consequence of antibiotic abuse or misuse is a view that is simplistic and inaccurate.
McMaster researchers discover a new antibacterial lead
Antibiotic resistance has been a significant problem for hospitals and health-care facilities for more than a decade. But despite the need for new treatment options, there have been only two new classes of antibiotics developed in the last 40 years.
Man-made crises 'outrunning our ability to deal with them,' scientists warn
The world faces a compounding series of crises driven by human activity, which existing governments and institutions are increasingly powerless to cope with, a group of eminent environmental scientists and economists has warned.
Genes key to staph disease severity, drug resistance found hitchhiking together
Scientists studying Staphylococcus bacteria, including methicillin-resistant S. aureus (MRSA), have discovered a potent staph toxin responsible for disease severity.
Resistance to antibiotics: When 1+1 is not 2
The evolution of multiple antibiotic resistances is a global and difficult problem to eradicate.
Ultrasensitive detector promises improved treatment of viral respiratory infections
A Vanderbilt chemist and a biomedical engineer have teamed up to develop a respiratory virus detector that is sensitive enough to detect an infection at an early stage, takes only a few minutes to return a result and is simple enough to be performed in a pediatrician's office.
Antibiotic prescribing should be standardized across Europe to help tackle resistance
Antibiotic prescribing for respiratory illnesses should be standardised across Europe to help reduce inappropriate prescribing and resistance.
More Antibiotic Resistance Current Events and Antibiotic Resistance News Articles
 |
Revenge Of The Microbes: How Bacterial Resistance Is Undermining The Antibiotic Miracle by Abigail A. Salyers (Author), Dixie D. Whitt (Author) 'What is antibiotic resistance, and why should I be concerned with it?' Media coverage and political and scientific discussions about 'superbugs' that defy our current treatments, genetically-modified foods in our fields and grocery stores, the threat of bioterrorism, and the use of antibiotics in agriculture have increased citizen awareness and fears regarding the issues surrounding antibiotic resistance. "Revenge of the Microbes: How Bacterial Resistance Is Undermining the Antibiotic Miracle" is a single source of answers to this and other questions average people are asking. Written by experts with extensive experience in the field, "Revenge of the Microbes" provides the scientific information readers will need to form opinions and make informed decisions regarding the use of... |
 |
The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers by Stuart B Levy (Author), M.D., Stuart B. Levy (Author) Revised and updated with a new introduction by the author, the classic book that warns consumers about the overuse of antibiotics. In this totally revised and updated edition of the classic primer on the misuse of antibiotics, Dr. Stuart Levy reveals how our cavalier and naïve attitude about the power of antibiotics can have -and already has had-dire consequences. He explains that we are currently witnessing a massive evolutionary change in bacteria. This build-up of new antibiotic-resistant bacteria in individuals and the environment, mixed with our overzealous use of antibiotic soaps and the unregulated dispensing of antibiotics worldwide, is leading us into a dangerous territory where our "miracle" drugs will no longer help. |
 |
Antibiotic Resistance: Stopping the Superbugs Antibiotics was once seen as super drugs. They rapidly disarmed pneumonia and many other previously fatal bacterial conditions, and had relatively few side effects. But the bacteria weren't ready to surrender yet. Strains emerged that were resistant to the world's most potent medicines and now we're facing a world-wide crisis. In this program we see how the problem developed and what the experts believe we need to do to win the battle. This program is part of the award winning public television series Healthy Body, Healthy Mind. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Antibiotic Resistance: Stopping the Superbugs Directed By: ITV Also With: ITV (Producer) |
 |
Antibiotics: Actions, Origins, Resistance by Christopher Walsh (Author) Harvard Medical School, Boston, MA. Text analyzes how small molecules interfere selectively with the processes central to the survival of bacterial cells. Focuses on the relatively few molecules in antibiotics having an impact on human infectious disease. DNLM: Antibiotics--pharmacology. |
 |
Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance (Rff Press) by Professor Ramanan Laxminarayan (Author), Professor Anup Malani (Author), Professor David Howard (Author), Professor David L. Smith (Author) Our ability to treat common bacterial infections with antibiotics goes back only 65 years. However, the authors of this report make it clear that sustaining a supply of effective and affordable antibiotics cannot be without changes to the incentives facing patients, physicians, hospitals, insurers, and pharmaceutical manufacturers. In fact, increasing resistance to these drugs is already exacting a terrible price. Every day in the United States, approximately 172 men, women, and children die from infections caused by antibiotic-resistant bacteria in hospitals alone. Beyond those deaths, antibiotic resistance is costing billions of dollars through prolonged hospital stays and the need for doctors to resort to ever more costly drugs to use as substitute treatments. Extending the... |
|
Resistance vs. Tolerance: Persistence as a Mechanism of Antibiotic Resistance CD-ROM Starring: Kim Lewis Directed By: Ryan Jordan | |
 |
Current Trends in Antibiotic Resistance in Infectious Diseases by Asad U. Khan (Author), Asad U. Khan (Editor) This book contains ten chapters which cover current trends on antibiotic resistance in different parts of the world. Some of the chapters are dedicated to specific type of bacteria like marine and cholera associated microorganisms. Whereas rest of the chapters are mainly focused on the mechanism of drug resistance with special reference to beta lactamases. Since most of the antibiotics used to treat infections belong to -lactam group which is lactam ring (?-lactam) or penam is a lactam with a heteroatomic ring structure, consisting of three carbon atoms and one nitrogen atom. A lactam is a cyclic amide. The main focus of this book is to understand the different molecular markers responsible for developing resistance against this group of antibiotics. CTX-M family... |
 |
Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition by Robert A. Bonomo (Editor), Marcelo E. Tolmasky (Editor) This book presents a state-of-the-art review of the mechanisms of resistance. The enzymes and enzyme systems detailed in this work include those involved in genetic reorganization, antibiotic modification and activation, antibiotic target modification, and antibiotic transport. |
 |
21st Century Complete Medical Guide to Antibiotics and Antibiotic Resistance, Drug-Resistant Bacteria, Antimicrobial Susceptibility, Authoritative CDC, ... for Patients and Physicians (CD-ROM) by PM Medical Health News (Author) This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of antibiotics and antibiotic resistance. This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor reference tools and texts have detailed technical information and clinical background material. The CDC's Campaign to Prevent Antimicrobial Resistance aims to prevent antimicrobial resistance in healthcare settings. The campaign centers on four main strategies: prevent infection, diagnose and treat infection, use... |
| © 2009 BrightSurf.com |